Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019–2020 - Top-Institutions - MDSpire

Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019–2020

  • By

  • Buhle Ntozini

  • Sibongile Walaza

  • Benjamin Metcalf

  • Scott Hazelhurst

  • Linda de Gouveia

  • Susan Meiring

  • Dineo Mogale

  • Senzo Mtshali

  • Arshad Ismail

  • Kedibone Ndlangisa

  • Mignon Du Plessis

  • Vanessa Quan

  • Sopio Chochua

  • Lesley McGee

  • Anne von Gottberg

  • Nicole Wolter

  • December 31, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Microbial Genomics
    • Epidemiology

  • #2

    University of Oxford, Nuffield Department of Medicine
    University of Oxford, Nuffield Department of Medicine

    Oxford, Oxfordshire

    Key Differentiators

    • Infectious Diseases
    • Microbial Genomics
    • Vaccine Research

  • #3

    University of Cape Town, Division of Medical Microbiology
    University of Cape Town, Division of Medical Microbiology

    Cape Town, Western Cape

    Key Differentiators

    • Medical Microbiology
    • Infectious Diseases
    • Epidemiology

  • #4

    Johns Hopkins University, Department of Molecular Microbiology and Immunology
    Johns Hopkins University, Department of Molecular Microbiology and Immunology

    Baltimore, MD

    Key Differentiators

    • Microbiology
    • Immunology
    • Vaccine Development

  • #5

    University of Washington, Vaccine and Infectious Disease Division
    University of Washington, Vaccine and Infectious Disease Division

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Vaccine Research
    • Microbial Genomics

Original Source(s)

Molecular Epidemiology of Invasive Group B Streptococcus in South Africa, 2019–2020

  • by Buhle Ntozini, Sibongile Walaza, Benjamin Metcalf, Scott Hazelhurst, Linda de Gouveia, Susan Meiring, Dineo Mogale, Senzo Mtshali, Arshad Ismail, Kedibone Ndlangisa, Mignon Du Plessis, Vanessa Quan, Sopio Chochua, Lesley McGee, Anne von Gottberg, Nicole Wolter

  • December 31, 2024

Related Content

Case Report: Severe sepsis due to imported scrub typhus in a German traveler returning from Vietnam

Dalbavancin Exposure Linked to Higher Success in Bacteremia

Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory

Characteristics and outcomes of type 2 myocardial infarction in sepsis survivors